DMAAU — DRUGS MADE IN AMER ACQUTN CO

As of Q2 2026, 1 SEC-registered investment managers reported holding DMAAU (DRUGS MADE IN AMER ACQUTN CO) in their latest 13F filings, with a combined reported value of $16.18K across 1.52K shares. That is +0.3% by share count (+4 shares) versus the previous quarter, while reported value moved +1.3%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.

DMAAU is classified in the Financials sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.